All public logs
Jump to navigation
Jump to search
Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 01:53, 8 May 2024 Edzelco talk contribs created page File:LOQTORZI Dosage.png
- 01:53, 8 May 2024 Edzelco talk contribs uploaded File:LOQTORZI Dosage.png
- 08:08, 17 April 2024 Edzelco talk contribs created page Elranatamab-bcmm (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:08, 17 April 2024 Edzelco talk contribs created page Palovarotene (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:08, 17 April 2024 Edzelco talk contribs created page Pozelimab-bbfg (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:07, 17 April 2024 Edzelco talk contribs created page Motixafortide (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:07, 17 April 2024 Edzelco talk contribs created page Momelotinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:06, 17 April 2024 Edzelco talk contribs created page Cipaglucosidase alfa-atga (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:05, 17 April 2024 Edzelco talk contribs created page Etrasimod (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:05, 17 April 2024 Edzelco talk contribs created page Zilucoplan (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:04, 17 April 2024 Edzelco talk contribs created page Bimekizumab (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:04, 17 April 2024 Edzelco talk contribs created page Vamorolone (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:04, 17 April 2024 Edzelco talk contribs created page Mirikizumab-mrkz (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:03, 17 April 2024 Edzelco talk contribs created page Toripalimab-tpzi (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} }}")
- 08:02, 17 April 2024 Edzelco talk contribs created page Fruquintinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=fruquintinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild‑type and medically appropriate, an anti-EGFR therapy |fdaLIADAdult=Recommended Dosage The recommended dose of F...")
- 07:52, 17 April 2024 Edzelco talk contribs created page Taurolidine, heparin (Created page with "{{DrugProjectFormSinglePage |authorTag={{Edzelco}} |genericName=taurolidine, heparin |aOrAn=a |drugClass=combination of taurolidine, a thiadiazinane antimicrobial, and heparin, an anti-coagulant |indicationType=prevention |indication=atheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients...")
- 07:43, 17 April 2024 Edzelco talk contribs created page Repotrectinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=repotrectinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) |contraindications=None |warnings=5.1 Central Nervous System Adverse Reactions AUGTYRO can cause central nervous system adverse reactions. Among the 351 patients who received AUGTYRO in Study TRIDENT-1, a broad spectru...")
- 07:32, 17 April 2024 Edzelco talk contribs created page Efbemalenograstim alfa-vuxw (Created page with "{{DrugProjectFormSinglePage |genericName=efbemalenograstim alfa-vuxw |aOrAn=a |drugClass=leukocyte growth factor |indicationType=prevention |indication=incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia |fdaLIADAdult=Recommended Dose: 20 mg administered subcutaneously once per chemotherapy cycle....")
- 05:50, 16 April 2024 Edzelco talk contribs created page Capivasertib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Capivasertib |aOrAn=a |drugClass=kinase inhibitor in combination with fulvestrant |indicationType=treatment |indication=adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN-alterations as detected by an FDA-approved test following progression on at least one endocrine-based...")
- 05:27, 16 April 2024 Edzelco talk contribs created page Iptacopan (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=iptacopan |aOrAn=a |drugClass=complement factor B inhibitor |indicationType=treatment |indication=paroxysmal nocturnal hemoglobinuria |blackBoxWarningTitle=WARNING: SERIOUS INFECTIONS CAUSED BY ENCAPSULATED BACTERIA |blackBoxWarningBody=<span style="clear;"> FABHALTA increases the risk of serious and life-threatening infections caused by encapsulated bacteria, including Streptococcus pneumoniae, Neisseria me...")
- 07:24, 15 April 2024 Edzelco talk contribs created page Vutrisiran (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=vutrisiran |aOrAn=a |drugClass=transthyretin-directed small interfering RNA |indicationType=treatment |indication=polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. |adverseReactions=pain in extremity, arthralgia, dyspnea, and decreased vitamin A levels. |fdaLIADAdult=Recommended Dosage The recommended dosage of AMVUTTRA is 25 mg administered by subcutaneous inj...")
- 22:23, 11 February 2024 Edzelco talk contribs created page Mavacamten (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=mavacamten |aOrAn=a |drugClass=cardiac myosin inhibitor |indicationType=treatment |indication=adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms |hasBlackBoxWarning=Yes |adverseReactions=dizziness (27%) and syncope (6%) |blackBoxWarningTitle=WARNING: RISK OF HEART...")
- 19:04, 10 February 2024 Edzelco talk contribs created page Oteseconazole (Created page with "{{DrugProjectFormSinglePage |genericName=oteseconazole |aOrAn=an |drugClass=azole antifungal |indicationType=prevention |indication=recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential |adverseReactions=headache and nausea |fdaLIADAdult=VIVJOA Capsules: 150 mg of oteseconazole in lavender hard gelatin capsules imprinted with OTE 150 in black ink. Fluconazole is not supplied in the carton. |co...")
- 19:02, 10 February 2024 Edzelco talk contribs created page File:VIVJOA label3.png
- 19:02, 10 February 2024 Edzelco talk contribs uploaded File:VIVJOA label3.png
- 19:02, 10 February 2024 Edzelco talk contribs created page File:VIVJOA label2.png
- 19:02, 10 February 2024 Edzelco talk contribs uploaded File:VIVJOA label2.png
- 19:02, 10 February 2024 Edzelco talk contribs created page File:VIVJOA label.png
- 19:02, 10 February 2024 Edzelco talk contribs uploaded File:VIVJOA label.png
- 19:02, 10 February 2024 Edzelco talk contribs created page File:VIVJOA structure.png
- 19:02, 10 February 2024 Edzelco talk contribs uploaded File:VIVJOA structure.png
- 00:47, 7 February 2024 Edzelco talk contribs created page Lutetium (177Lu) vipivotide tetraxetan (Created page with "{{DrugProjectFormSinglePage |genericName=lutetium (177Lu) vipivotide tetraxetan |aOrAn=a |drugClass=radioligand therapeutic agent |indicationType=treatment |indication=adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy |adverseReactions=fatigue, dry mout...")
- 00:44, 7 February 2024 Edzelco talk contribs created page File:Pluvicto label.png
- 00:44, 7 February 2024 Edzelco talk contribs uploaded File:Pluvicto label.png
- 00:44, 7 February 2024 Edzelco talk contribs created page File:Pluvicto structure.png
- 00:44, 7 February 2024 Edzelco talk contribs uploaded File:Pluvicto structure.png
- 00:57, 6 February 2024 Edzelco talk contribs created page Nivolumab and relatlimab-rmbw (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=nivolumab and relatlimab-rmbw |aOrAn=a |drugClass=combination of nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody |indicationType=treatment |indication=adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma |adverseReactions=immune-mediated pneumonitis, im...")
- 00:56, 6 February 2024 Edzelco talk contribs created page File:Nivolumab and relatlimab-rmbw label.png
- 00:56, 6 February 2024 Edzelco talk contribs uploaded File:Nivolumab and relatlimab-rmbw label.png
- 00:22, 6 February 2024 Edzelco talk contribs created page File:Ganaloxone bottle carton.png
- 00:22, 6 February 2024 Edzelco talk contribs uploaded File:Ganaloxone bottle carton.png
- 00:22, 6 February 2024 Edzelco talk contribs created page File:Ganaloxone bottle suspension label 50mg.png
- 00:22, 6 February 2024 Edzelco talk contribs uploaded File:Ganaloxone bottle suspension label 50mg.png
- 00:21, 6 February 2024 Edzelco talk contribs created page File:Ganaloxone structure.png
- 00:21, 6 February 2024 Edzelco talk contribs uploaded File:Ganaloxone structure.png
- 15:47, 2 February 2024 Edzelco talk contribs created page Pacritinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Pacritinib |aOrAn=a |drugClass=kinase inhibitor |indicationType=treatment |indication=adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 × 109/L (1) |adverseReactions=diarrhea, thrombocytopenia, nausea, anemia, and peripheral edema |fdaLIADAdult=The recommended dosage of VONJO is 200 mg orally twi...")
- 15:47, 2 February 2024 Edzelco talk contribs created page File:Pacritinib Bottle Label.png
- 15:47, 2 February 2024 Edzelco talk contribs uploaded File:Pacritinib Bottle Label.png
- 15:47, 2 February 2024 Edzelco talk contribs created page File:Pacritinib Carton Label.png
- 15:47, 2 February 2024 Edzelco talk contribs uploaded File:Pacritinib Carton Label.png
- 15:47, 2 February 2024 Edzelco talk contribs created page File:Pacritinib supply.png
- 15:47, 2 February 2024 Edzelco talk contribs uploaded File:Pacritinib supply.png
- 15:47, 2 February 2024 Edzelco talk contribs created page File:Pacritinib structure.png
- 15:47, 2 February 2024 Edzelco talk contribs uploaded File:Pacritinib structure.png
- 16:13, 1 February 2024 Edzelco talk contribs created page Mitapivat (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=mitapivat |aOrAn=a |drugClass=pyruvate kinase activator |indicationType=treatment |indication=hemolytic anemia in adults with pyruvate kinase (PK) deficiency |adverseReactions=estrone decreased (males), increased urate, back pain, estradiol decreased (males), and arthralgia |fdaLIADAdult=PYRUKYND is taken with or without food and swallowed whole. Do not split, crush, chew,...")
- 16:08, 1 February 2024 Edzelco talk contribs created page File:Mitapivat 5mg.png
- 16:08, 1 February 2024 Edzelco talk contribs uploaded File:Mitapivat 5mg.png
- 16:08, 1 February 2024 Edzelco talk contribs created page File:Mitapivat 5mg tablet blister pack.png
- 16:08, 1 February 2024 Edzelco talk contribs uploaded File:Mitapivat 5mg tablet blister pack.png
- 16:07, 1 February 2024 Edzelco talk contribs created page File:Mitapivat 20mg.png
- 16:07, 1 February 2024 Edzelco talk contribs uploaded File:Mitapivat 20mg.png
- 16:07, 1 February 2024 Edzelco talk contribs created page File:Mitapivat 20mg tablet blister pack.png
- 16:07, 1 February 2024 Edzelco talk contribs uploaded File:Mitapivat 20mg tablet blister pack.png
- 16:07, 1 February 2024 Edzelco talk contribs created page File:Mitapivat 50mg.png
- 16:07, 1 February 2024 Edzelco talk contribs uploaded File:Mitapivat 50mg.png
- 16:07, 1 February 2024 Edzelco talk contribs created page File:Mitapivat 50mg tablet blister pack.png
- 16:07, 1 February 2024 Edzelco talk contribs uploaded File:Mitapivat 50mg tablet blister pack.png
- 16:06, 1 February 2024 Edzelco talk contribs created page File:Mitapivat structure.png
- 16:06, 1 February 2024 Edzelco talk contribs uploaded File:Mitapivat structure.png
- 16:06, 1 February 2024 Edzelco talk contribs created page File:Mitapivat supply.png
- 16:06, 1 February 2024 Edzelco talk contribs uploaded File:Mitapivat supply.png
- 15:46, 1 February 2024 Edzelco talk contribs created page Sutimlimab-jome (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Sutimlimab-jome |aOrAn=a |drugClass=classical complement inhibitor |indicationType=treatment |indication=hemolysis in adults with cold agglutinin disease (CAD) |adverseReactions=in the CADENZA study (Part A) (incidence ≥18%) are rhinitis, headache, hypertension, acrocyanosis, and Raynaud's phenomenon. The most common adverse reactions in the CARDINAL study (incidence ≥...")
- 15:44, 1 February 2024 Edzelco talk contribs created page File:Sutimlimab-jome packaging.png
- 15:44, 1 February 2024 Edzelco talk contribs uploaded File:Sutimlimab-jome packaging.png
- 15:31, 1 February 2024 Edzelco talk contribs created page Faricimab-svoa (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Faricimab-svoa |aOrAn=a |drugClass=vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2) inhibitor |indicationType=treatment |indication=patients with neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO) |adverseReactions=cataract (15%) and [[conjunctival hemorrhage]...")
- 14:59, 1 February 2024 Edzelco talk contribs created page Tebentafusp-tebn (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Tebentafusp-tebn |aOrAn=a |drugClass=bispecific gp100 peptide-HLA-directed CD3 T cell engager |indicationType=treatment |indication=HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma |hasBlackBoxWarning=Yes |adverseReactions=cytokine release syndrome, rash, pyrexia, pruritus, fatigue, nausea, chills, abdominal pain, edema, hypotension, dry skin, headache and vomiting. The most...")
- 01:46, 1 February 2024 Edzelco talk contribs created page File:Abrocitinib 200mg.png
- 01:46, 1 February 2024 Edzelco talk contribs uploaded File:Abrocitinib 200mg.png
- 01:46, 1 February 2024 Edzelco talk contribs created page File:Abrocitinib 100mg.png
- 01:46, 1 February 2024 Edzelco talk contribs uploaded File:Abrocitinib 100mg.png
- 01:43, 1 February 2024 Edzelco talk contribs created page File:Abrocitinib 50mg.png
- 01:43, 1 February 2024 Edzelco talk contribs uploaded File:Abrocitinib 50mg.png
- 01:39, 1 February 2024 Edzelco talk contribs created page File:Abrocitinib supply.png
- 01:39, 1 February 2024 Edzelco talk contribs uploaded File:Abrocitinib supply.png
- 01:32, 1 February 2024 Edzelco talk contribs created page File:Abrocitinib.png
- 01:32, 1 February 2024 Edzelco talk contribs uploaded File:Abrocitinib.png
- 01:31, 1 February 2024 Edzelco talk contribs created page Abrocitinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |indicationType=treatment |indication=adults and pediatric patients 12 years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable. |blackBoxWarningTitle=WARNING: SERIOUS INFECTIONS, MORTALITY, MALIGNANCY, MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE), and THROMBOS...")
- 21:17, 31 January 2024 Edzelco talk contribs created page Daridorexant (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=daridorexant |aOrAn=an |drugClass=orexin receptor antagonist |indicationType=treatment |indication=adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance |adverseReactions=Common adverse reactions (reported in ≥ 5% of patients treated with QUVIVIQ and at an incidence ≥ than placebo) include headache and somnolence or fatigue...")
- 21:15, 31 January 2024 Edzelco talk contribs created page File:Clinical Studies 3.png
- 21:15, 31 January 2024 Edzelco talk contribs uploaded File:Clinical Studies 3.png
- 21:15, 31 January 2024 Edzelco talk contribs created page File:Clinical Studies 2.png
- 21:15, 31 January 2024 Edzelco talk contribs uploaded File:Clinical Studies 2.png
- 21:15, 31 January 2024 Edzelco talk contribs created page File:Clinical Studies 1.png
- 21:15, 31 January 2024 Edzelco talk contribs uploaded File:Clinical Studies 1.png
- 21:07, 31 January 2024 Edzelco talk contribs created page File:Effects of hepatic impairment and renal impairment on daridorexant PK.png
- 21:07, 31 January 2024 Edzelco talk contribs uploaded File:Effects of hepatic impairment and renal impairment on daridorexant PK.png
- 21:07, 31 January 2024 Edzelco talk contribs created page File:Effect of daridorexant on the PK of other compounds.png
- 21:07, 31 January 2024 Edzelco talk contribs uploaded File:Effect of daridorexant on the PK of other compounds.png
- 21:06, 31 January 2024 Edzelco talk contribs created page File:Effect of co-administered compounds on the PK of daridorexant.png
- 21:06, 31 January 2024 Edzelco talk contribs uploaded File:Effect of co-administered compounds on the PK of daridorexant.png
- 21:01, 31 January 2024 Edzelco talk contribs created page File:Packaging 3.png
- 21:01, 31 January 2024 Edzelco talk contribs uploaded File:Packaging 3.png
- 21:01, 31 January 2024 Edzelco talk contribs created page File:Packaging 2.png
- 21:01, 31 January 2024 Edzelco talk contribs uploaded File:Packaging 2.png
- 21:00, 31 January 2024 Edzelco talk contribs created page File:Packaging 1.png
- 21:00, 31 January 2024 Edzelco talk contribs uploaded File:Packaging 1.png
- 20:49, 31 January 2024 Edzelco talk contribs created page File:Daridorexant.png
- 20:49, 31 January 2024 Edzelco talk contribs uploaded File:Daridorexant.png
- 00:25, 25 January 2024 Edzelco talk contribs created page Orbifloxacin (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Orbifloxacin |aOrAn=a |drugClass=fluoroquinolone carboxylic acid derivatives |indicationType=treatment |indication=urinary tract infections (cystitis) in dogs caused by susceptible strains of <i>Staphylococcus pseudintermedius, Proteus mirabilis, Escherichia coli</i> and <i>Enterococcus faecalis</i>. |adverseReactions=In a field study, when the tablet formulation of orbifloxacin...")
- 00:16, 25 January 2024 Edzelco talk contribs created page File:Orbifloxacin packaging.png
- 00:16, 25 January 2024 Edzelco talk contribs uploaded File:Orbifloxacin packaging.png
- 00:15, 25 January 2024 Edzelco talk contribs created page File:Orbifloxacin suspension 2.png
- 00:15, 25 January 2024 Edzelco talk contribs uploaded File:Orbifloxacin suspension 2.png
- 00:15, 25 January 2024 Edzelco talk contribs created page File:Orbifloxacin suspension.png
- 00:15, 25 January 2024 Edzelco talk contribs uploaded File:Orbifloxacin suspension.png
- 00:15, 25 January 2024 Edzelco talk contribs created page File:Orbifloxacin structure.png
- 00:15, 25 January 2024 Edzelco talk contribs uploaded File:Orbifloxacin structure.png
- 14:28, 23 January 2024 Edzelco talk contribs created page Ado-Trastuzumab Emtansine (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Ado-trastuzumab emtansine |aOrAn=a |drugClass=HER2-targeted antibody and microtubule inhibitor conjugate |indicationType=treatment |indication=1.) patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either: a.) Received prior therapy for metastatic disease, or b.) Developed disease recurrence during or wi...")
- 14:24, 23 January 2024 Edzelco talk contribs created page File:Ado-trastuzumab emtansine packaging 160mg.png
- 14:24, 23 January 2024 Edzelco talk contribs uploaded File:Ado-trastuzumab emtansine packaging 160mg.png
- 14:22, 23 January 2024 Edzelco talk contribs created page File:Ado-trastuzumab emtansine packaging.png
- 14:22, 23 January 2024 Edzelco talk contribs uploaded File:Ado-trastuzumab emtansine packaging.png
- 14:19, 23 January 2024 Edzelco talk contribs created page File:Ado-trastuzumab emtansine supply.png
- 14:19, 23 January 2024 Edzelco talk contribs uploaded File:Ado-trastuzumab emtansine supply.png
- 14:19, 23 January 2024 Edzelco talk contribs created page File:Ado-trastuzumab emtansine structure.png
- 14:19, 23 January 2024 Edzelco talk contribs uploaded File:Ado-trastuzumab emtansine structure.png
- 23:32, 22 January 2024 Edzelco talk contribs created page Omacetaxine mepesuccinate (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Omacetaxine mepesuccinate (SYNRIBO) |aOrAn=an |drugClass=injection |indicationType=treatment |indication=adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI) |fdaLIADAdult=*Induction Dose: 1.25 mg/m2 administered by subcutaneous injection twice daily for 14 consecutive days of a 28-day cycle. *Maint...")
- 23:08, 22 January 2024 Edzelco talk contribs created page Adipiodone (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Adipiodone meglumine |aOrAn=a |drugClass=a tri-iodinated benzoate derivative and an ionic dimeric contrast agent |indicationType=procedure |indication=diagnostic imaging, as this agent blocks x-ray and appears opaque on x-ray film; thereby it enhances the visibility of the bile ducts and gallbladder during cholangiography and cholecystography procedures |adverseReactions=epilepsy, abdominal pain, and tremor...")
- 21:17, 22 January 2024 Edzelco talk contribs created page File:Adipiodine FDA-Approved Drugs.png
- 21:17, 22 January 2024 Edzelco talk contribs uploaded File:Adipiodine FDA-Approved Drugs.png
- 21:12, 22 January 2024 Edzelco talk contribs created page File:Structure of Adipiodine.png
- 21:12, 22 January 2024 Edzelco talk contribs uploaded File:Structure of Adipiodine.png
- 16:42, 22 January 2024 Edzelco talk contribs created page File:Oclatinib.png
- 16:42, 22 January 2024 Edzelco talk contribs uploaded File:Oclatinib.png
- 16:37, 22 January 2024 Edzelco talk contribs created page Oclacitinib (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |aOrAn=an |drugClass=immunomodulator |indicationType=treatment |indication=pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age |blackBoxWarningBody=This product is not for human use. Keep this and all drugs out of reach of children. For use in dogs only. Wash hands immediately after handling the tablets. In case of accidental eye contact, flush immediately with...")
- 16:34, 22 January 2024 Edzelco talk contribs created page File:APOQUEL tablets 16 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs uploaded File:APOQUEL tablets 16 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs created page File:APOQUEL tablets 5.4 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs uploaded File:APOQUEL tablets 5.4 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs created page File:APOQUEL tablets 3.6 mg Tablet Bottle Label.png
- 16:34, 22 January 2024 Edzelco talk contribs uploaded File:APOQUEL tablets 3.6 mg Tablet Bottle Label.png
- 15:49, 22 January 2024 Edzelco talk contribs created page Absorbable gelatin sponge (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Gelatin Sponge, Absorbable |aOrAn=a |drugClass=sterile, gelatin-base surgical sponge |indicationType=treatment |indication=bleeding as an adjunct to hemostasis when conventional procedure is ineffective. |brandNames=*Gelfoam |lookAlike=*Gelaspon *SurgiFoam }}")
- 00:21, 22 January 2024 Edzelco talk contribs created page File:2-(4-CHLOROPHENOXY)ETHANOL.png
- 00:21, 22 January 2024 Edzelco talk contribs uploaded File:2-(4-CHLOROPHENOXY)ETHANOL.png
- 22:16, 21 January 2024 Edzelco talk contribs created page AbobotulinumtoxinA (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=Dysport |indication=Dysport is FDA approved for the treatment of cervical dystonia in adults, improvement of moderate to severe frown lines on the glabellar zone (eyebrows) of adults aged 65 years old or younger for a short period of time, and spasticity in people aged 2 years or older. |adverseReactions=Common adverse reactions include difficulty in breathing, speak...")
- 21:28, 21 January 2024 Edzelco talk contribs created page 2-(4-chlorphenoxy)-ethanol (Created page with "{{DrugProjectFormSinglePage |authorTag={{CMG}}; {{EdzelCo}} }}")
- 07:00, 13 November 2023 Edzelco talk contribs created page Cardiomyopathy 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy (Created page with "2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy")
- 06:58, 13 November 2023 Edzelco talk contribs created page Cardiomyopathy 2023 ESC Guideline Recommendations (Created page with "=== <b><font color="red"> 2023 ESC Guideline Recommendations </font> </b> <ref name="pmid37622657">{{cite journal| author=Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C | display-authors=etal| title=2023 ESC Guidelines for the management of cardiomyopathies. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 37 | pages= 3503-3626 | pmid=37622657 | doi=10.1093/eurheartj/ehad194 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/el...")
- 06:46, 13 November 2023 Edzelco talk contribs created page Cardiomyopathy Guidelines (Created page with "=== <b><font color="red"> 2023 ESC Guideline Recommendations </font> </b> <ref name="pmid37622657">{{cite journal| author=Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C | display-authors=etal| title=2023 ESC Guidelines for the management of cardiomyopathies. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 37 | pages= 3503-3626 | pmid=37622657 | doi=10.1093/eurheartj/ehad194 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/el...")
- 15:15, 10 August 2023 Edzelco talk contribs created page Adams–Oliver syndrome (Created page with "{{EdzelCo}}")
- 21:20, 9 July 2023 Edzelco talk contribs created page File:Bernard Lown.jpg
- 21:20, 9 July 2023 Edzelco talk contribs uploaded File:Bernard Lown.jpg
- 21:08, 9 July 2023 Edzelco talk contribs created page File:Claude Beck.jpg
- 21:08, 9 July 2023 Edzelco talk contribs uploaded File:Claude Beck.jpg
- 20:53, 9 July 2023 Edzelco talk contribs created page File:William Kouwenhoven.jpg
- 20:53, 9 July 2023 Edzelco talk contribs uploaded File:William Kouwenhoven.jpg
- 20:15, 9 July 2023 Edzelco talk contribs created page File:Carl Ludwig.jpg
- 20:15, 9 July 2023 Edzelco talk contribs uploaded File:Carl Ludwig.jpg
- 19:33, 7 July 2023 Edzelco talk contribs created page File:John Erichsen.jpg
- 19:33, 7 July 2023 Edzelco talk contribs uploaded File:John Erichsen.jpg
- 19:29, 7 July 2023 Edzelco talk contribs created page File:Vesalius.jpg
- 19:29, 7 July 2023 Edzelco talk contribs uploaded File:Vesalius.jpg
- 16:07, 6 July 2023 Edzelco talk contribs uploaded a new version of File:Hippocrates.jpg
- 05:24, 25 January 2023 Edzelco talk contribs created page File:ProfJAMpicl1.png
- 05:24, 25 January 2023 Edzelco talk contribs uploaded File:ProfJAMpicl1.png
- 02:42, 10 April 2022 Edzelco talk contribs created page File:Xray gas gangrene.jpg
- 02:42, 10 April 2022 Edzelco talk contribs uploaded File:Xray gas gangrene.jpg
- 02:40, 10 April 2022 Edzelco talk contribs uploaded a new version of File:Gas gangrene.jpg
- 14:36, 7 April 2022 Edzelco talk contribs created page File:Camille Bulcke.jpg
- 14:36, 7 April 2022 Edzelco talk contribs uploaded File:Camille Bulcke.jpg
- 14:20, 7 April 2022 Edzelco talk contribs created page File:Sebald Justinus Brugmans.jpg
- 14:20, 7 April 2022 Edzelco talk contribs uploaded File:Sebald Justinus Brugmans.jpg
- 14:11, 7 April 2022 Edzelco talk contribs created page File:King Louis XIV.jpg
- 14:11, 7 April 2022 Edzelco talk contribs uploaded File:King Louis XIV.jpg
- 05:45, 7 April 2022 Edzelco talk contribs created page File:Jean Baptiste Lully.jpg
- 05:45, 7 April 2022 Edzelco talk contribs uploaded File:Jean Baptiste Lully.jpg
- 07:09, 4 April 2022 Edzelco talk contribs created page File:Gangrenous skull.png
- 07:09, 4 April 2022 Edzelco talk contribs uploaded File:Gangrenous skull.png
- 06:50, 4 April 2022 Edzelco talk contribs created page File:Necrotizing fasciitis.png
- 06:50, 4 April 2022 Edzelco talk contribs uploaded File:Necrotizing fasciitis.png
- 06:50, 4 April 2022 Edzelco talk contribs created page File:Gangrenous hemiscrotum.png
- 06:50, 4 April 2022 Edzelco talk contribs uploaded File:Gangrenous hemiscrotum.png
- 06:49, 4 April 2022 Edzelco talk contribs created page File:Gangrene of face.png
- 06:49, 4 April 2022 Edzelco talk contribs uploaded File:Gangrene of face.png
- 06:48, 4 April 2022 Edzelco talk contribs created page File:Gangrene of digits.png
- 06:48, 4 April 2022 Edzelco talk contribs uploaded File:Gangrene of digits.png
- 06:37, 4 April 2022 Edzelco talk contribs created page File:Gangrene of extremities.png
- 06:37, 4 April 2022 Edzelco talk contribs uploaded File:Gangrene of extremities.png
- 06:26, 4 April 2022 Edzelco talk contribs uploaded a new version of File:Noma.jpg
- 13:56, 3 April 2022 Edzelco talk contribs uploaded a new version of File:Gas gangrene.jpg
- 13:02, 3 April 2022 Edzelco talk contribs created page File:Dry gangrene.jpeg
- 13:02, 3 April 2022 Edzelco talk contribs uploaded File:Dry gangrene.jpeg
- 12:02, 11 March 2022 Edzelco talk contribs created page Cavernous angioma medical therapy (Created page with "== Overview == There is no definite medical treatment for cavernous angioma. However, symptoms associated with this condition are being treated individually. ==...")
- 06:55, 27 February 2022 Edzelco talk contribs created page File:Cavernous hemangioma of orbit.jpg
- 06:55, 27 February 2022 Edzelco talk contribs uploaded File:Cavernous hemangioma of orbit.jpg
- 06:38, 26 February 2022 Edzelco talk contribs created page File:Cavernous angioma.jpg (This is a microscopic pathology picture of cavernous angioma.)
- 06:38, 26 February 2022 Edzelco talk contribs uploaded File:Cavernous angioma.jpg (This is a microscopic pathology picture of cavernous angioma.)
- 07:18, 16 February 2022 Edzelco talk contribs created page Cavernous angioma (patient information) (Added subheadings) Tag: Visual edit
- 11:49, 14 February 2022 Edzelco talk contribs created page File:Edzel Co.jpg
- 11:49, 14 February 2022 Edzelco talk contribs uploaded File:Edzel Co.jpg
- 11:42, 14 February 2022 Edzelco talk contribs moved page File:Med gradpic.jpg to File:Edzel Lorraine Co.jpg (Uploaded in a wrong page)
- 11:17, 14 February 2022 Edzelco talk contribs created page File:Med gradpic.jpg
- 11:17, 14 February 2022 Edzelco talk contribs uploaded File:Med gradpic.jpg